AminoLogics

What AminoLogics does

AminoLogics (legal name: aminologics co.,ltd) is a South Korea–based specialty biochemicals manufacturer founded in 1997 and headquartered at Samsung Building 3F, 151 Yeoksam-ro, Gangnam-gu, Seoul. The company manufactures and sells optically pure amino acids—primarily D-amino acids—and amino acid derivatives for industrial applications in pharmaceuticals, agrochemicals, food/feed, and life-science research. Its core technology is the proprietary ARCA (Axially Chiral Relay Array) chiral separation platform, deployed via two complementary processes: a Shuttle Process that uses a Phase Transfer Catalyst to form an optically selective imine from DL-amino acids, recovers the unreacted excess for direct reuse or racemization-and-reuse, and hydrolyzes the imine to liberate D-amino acid; and a Conversion Process that achieves epimerization of the alpha-proton by excess base, then hydrolyzes to yield D-amino acid. In both processes, the ARCA chiral selector is recovered and immediately reused in the subsequent reaction, reducing raw-material consumption.

The business model is B2B direct sales of manufactured amino acid building blocks to industrial customers across four horizontal end-markets (pharmaceuticals, agrochemicals, food/feed, and research organizations), with customer engagement handled through the company's website inquiry system rather than through disclosed channel partners, distributors, or licensing arrangements. Pricing is not publicly disclosed. The company is co-led by founders Seongseok Oh and Jangseok Oh as co-CEOs, maintains an R&D center, and operates an investor relations infrastructure—stock information, disclosure postings, AGM notices (29th AGM convened March 31, 2026), and a personal-data-protection policy—consistent with a KOSDAQ-listed entity. Two related pharmaceutical firms, Samoh Pharmachem (삼오파마켐) and Saehan Pharm (새한제약), are listed as family sites though no formal ownership relationship is documented. With a stated headcount of 11–50 employees and no publicly disclosed revenue figures, AminoLogics operates as a small, technology-IP-driven specialty biochemicals supplier.

Name

AminoLogics

Legal name

aminologics co.,ltd

Website

https://aminologics.co.kr

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

AminoLogics is a South Korea–based specialty biochemical manufacturer founded in 1997 that uses its proprietary ARCA chiral separation platform to produce optically pure D- and L-amino acids for pharmaceutical, agrochemical, food/feed, and life-science research customers through direct B2B sales.

Ownership category

akta.pro rank

Product category

Specialty Chemicals Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)

akta.pro primary industry

Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE)

akta.pro secondary industry

Amino Acids & Peptides (BCAAs, Collagen Peptides, Bioactive Peptides, L-Theanine) (AFAJAKAG)

Keywords

• Amino acid manufacturing
• Chiral separation technology
• Specialty chemicals production
• Amino acid derivatives
• Life science ingredients

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure

Revenue model

1. Amino Acid Manufacturing and Supply: AminoLogics manufactures and supplies amino acids for industrial applications including research, pharmaceuticals, agrochemicals, and food and feed industries. The company utilizes proprietary chiral technology to produce optically pure amino acids.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

AminoLogics manufactures and sells amino acids and amino acid derivatives, using its proprietary ARCA (Axially Chiral Relay Array) chiral separation technology alongside Shuttle and Conversion processes. The products are targeted at life-science, pharmaceutical, and industrial customers requiring high-purity chiral amino acid inputs. The company supports its production with an in-house R&D center focused on process innovation and quality.

Product overview

AminoLogics is a biotechnology company specializing in amino acid manufacturing and chiral technology. Their core offering centers on ARCA technology for optical resolution and conversion of amino acids, enabling the production of optically pure D-amino acids and L-amino acids. The company provides amino acids as building blocks for various industrial applications including research, pharmaceuticals, agrochemicals, and food/feed industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Amino Acids and Amino Acid Derivatives Manufactured amino acids and amino acid derivatives produced via the proprietary ARCA (Axially Chiral Relay Array) chiral separation process, supplied to pharmaceutical, agrochemical, food, and life-science industrial buyers requiring high-purity chiral inputs.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Bachem: Swiss peptide and amino acid API manufacturer serving pharma; broader portfolio than AminoLogics but a directly comparable specialty amino acid/chiral API CDMO competitor.
• Ajinomoto: Global leader in amino acid production for pharmaceuticals, food, and feed with extensive chiral amino acid capability; a much larger incumbent operating in AminoLogics' exact categories.
• Evonik Industries: German specialty chemicals major with a dedicated amino acids and chiral intermediates business serving pharma and agrochemical customers; broad incumbent with overlapping amino acid/chiral capabilities.
• WuXi AppTec: Chinese CRDMO with extensive chiral chemistry and small-molecule manufacturing capabilities serving global pharma; broader scope but a comparable chiral intermediates supplier.
• CordenPharma: Global CDMO with peptide and small-molecule API manufacturing, including chiral intermediates — comparable to AminoLogics' chiral amino acid manufacturing value proposition.

Emerging players

• Peptron: Korean peptide and amino acid derivative CDMO; smaller emerging player with overlapping specialty amino acid and chiral chemistry capabilities in the same domestic market.

Direct peers

• Iris Biotech: German supplier of specialty amino acids, peptides, and chiral building blocks for pharma and research — closely comparable niche specialty amino acid competitor.
• Kyowa Hakko Bio: Japanese amino acid manufacturer producing L-, D-, and specialty amino acids for pharma, food, and industrial markets — directly comparable to AminoLogics' core product line and end-markets.
• Chengdu Baishixing: Chinese producer of amino acids and derivatives including D- and specialty amino acids for pharma and food — comparable scale Asian amino acid manufacturer.
• Sichuan Tongsheng Amino Acid: Chinese manufacturer of L- and D-amino acids for pharmaceutical, food, and feed applications — direct competitor in the same amino acid categories AminoLogics serves.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AminoLogics